EMA Fees: Parliamentary Committee Insists On Full Transparency & Sufficient Funding

A European Parliament committee has backed a draft regulation intended to simplify the fee structure at the European Medicines Agency but cautioned that the fees must be based on a “transparent evaluation” of the estimates of workload and related regulatory costs.

The environment and public health (ENVI) committee also insisted that sufficient funding was needed for both the EMA and the national competent authorities (NCAs) to ensure their long-term sustainability, and that the fees